Palmetto

Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test

Palmetto Finalizes Medicare Coverage for MRD Cancer Testing

Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage

Veracyte Bladder Cancer Test Receives Medicare Coverage

Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests

Bucking Downward 2021 Trend, 360Dx Index Rebounds 4 Percent in April

Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection

360Dx Index Jumps 31 Percent in 2020 as COVID-19 Shifts Attention to Dx Industry

Local Coverage Determinations Roundup: Castle Bio

CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests

Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests

Strata Oncology Receives Medicare Coverage for NGS Test

Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences

Castle Bio Receives Expanded Medicare Coverage for Melanoma Test

CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Two Medicare Contractors Align Coverage for MRD Testing With Palmetto

Natera Receives LCD From Palmetto for Signatera MRD Test in Colorectal Cancer Patients

NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing